688185 康希诺
已收盘 12-19 15:00:00
资讯
新帖
简况
康希诺12月17日获主力加仓898万元 环比增加897.78%
市场透视 · 12-17 15:21
康希诺12月17日获主力加仓898万元 环比增加897.78%
《股市简讯》中国康希诺A/H股齐涨，婴幼儿百白破疫苗上市申请获药监局受理
路透中文 · 12-17 10:13
《股市简讯》中国康希诺A/H股齐涨，婴幼儿百白破疫苗上市申请获药监局受理
康希诺最新公告：婴幼儿用吸附无细胞百（组分）白破联合疫苗药品注册申请获得受理
证券之星 · 12-16 17:00
康希诺最新公告：婴幼儿用吸附无细胞百（组分）白破联合疫苗药品注册申请获得受理
康希诺：婴幼儿用组分白破联合疫苗注册申请获受理
美港电讯 · 12-16 16:59
康希诺：婴幼儿用组分白破联合疫苗注册申请获受理
康希诺(688185.SH)：婴幼儿用吸附无细胞百(组分)白破联合疫苗药品注册申请获得受理
智通财经 · 12-16
康希诺(688185.SH)：婴幼儿用吸附无细胞百(组分)白破联合疫苗药品注册申请获得受理
康希诺12月13日主力资金流出942万元 连续5日减仓
市场透视 · 12-13
康希诺12月13日主力资金流出942万元 连续5日减仓
康希诺在互动平台表示，公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报。
美港电讯 · 12-13
康希诺在互动平台表示，公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报。
康希诺：公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报
证星董秘互动 · 12-12
康希诺：公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报
康希诺生物盘中异动 早盘急速下跌5.11%
市场透视 · 12-12
康希诺生物盘中异动 早盘急速下跌5.11%
南向资金12月11日净买入康希诺生物8.46万股 连续5日增持
市场透视 · 12-12
南向资金12月11日净买入康希诺生物8.46万股 连续5日增持
康希诺（688185）12月11日主力资金净卖出1330.47万元
证券之星 · 12-12
康希诺（688185）12月11日主力资金净卖出1330.47万元
康希诺12月11日主力资金流出1164万元 连续3日减仓
市场透视 · 12-11
康希诺12月11日主力资金流出1164万元 连续3日减仓
康希诺生物盘中异动 急速拉升5.14%
市场透视 · 12-11
康希诺生物盘中异动 急速拉升5.14%
康希诺（688185）12月9日主力资金净卖出2400.82万元
证券之星 · 12-10
康希诺（688185）12月9日主力资金净卖出2400.82万元
康希诺12月06日获主力加仓2540万元 环比增加10943.48%
市场透视 · 12-06
康希诺12月06日获主力加仓2540万元 环比增加10943.48%
康希诺股价涨5% 券商看多
智选洞察 · 12-06
康希诺股价涨5% 券商看多
康希诺生物盘中异动 早盘急速上涨5.17%
市场透视 · 12-06
康希诺生物盘中异动 早盘急速上涨5.17%
康希诺现涨超5% 近日MCV4药品补充申请获国家药监局受理
新浪港股 · 12-05
康希诺现涨超5% 近日MCV4药品补充申请获国家药监局受理
港股异动 | 康希诺(06185)涨超4% 近日MCV4药品补充申请获国家药监局受理
智通财经 · 12-05
港股异动 | 康希诺(06185)涨超4% 近日MCV4药品补充申请获国家药监局受理
康希诺生物盘中异动 早盘股价大涨5.19%报31.400港元
市场透视 · 12-05
康希诺生物盘中异动 早盘股价大涨5.19%报31.400港元
加载更多
公司概况
公司名称：
康希诺生物股份公司
所属行业：
医药制造业
上市日期：
2020-08-13
主营业务：
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。
发行价格：
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":63.28,"timestamp":1734591600000,"preClose":63.29,"halted":0,"volume":1328300,"delay":0,"floatShares":114999999,"shares":247000000,"eps":-2.9102,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.01,"latestTime":"12-19 15:00:00","open":62.78,"high":63.51,"low":61.8,"amount":83338900,"amplitude":0.027,"askPrice":63.28,"askSize":17,"bidPrice":63.26,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-2.9102,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":63.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":69.62,"lowLimit":56.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"pbRate":3.09,"roa":"--","roe":"--","epsLYR":-6.01,"committee":0.473251,"marketValue":15659000000,"floatMarketCap":7263000000,"peRate":-21.744209,"changeRate":-0.0002,"turnoverRate":0.0116,"status":1,"afterMarket":{"amount":0,"volume":0,"close":63.28,"buyVolume":0,"sellVolume":200,"time":1734593638975,"indexStatus":"已收盘 12-19 15:30:00","preClose":63.29}},"requestUrl":"/m/hq/s/688185","defaultTab":"news","newsList":[{"id":"2492389955","title":"康希诺12月17日获主力加仓898万元 环比增加897.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492389955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492389955?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:21","pubTimestamp":1734420114,"startTime":"0","endTime":"0","summary":"12月17日, 康希诺股价跌0.62%，报收63.68元，成交金额1.01亿元，换手率1.36%，振幅3.60%，量比0.85。康希诺今日主力资金净流入898万元，上一交易日主力净流入90万元，今日环比增加897.78%。|12月17日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|安妮股份|7.49%|#|奥拓电子|6.92%|#|福日电子|6.87%|#|卓翼科技|6.56%|#|天娱数科|5.38%|#|三柏硕|4.53%|#|威领股份|4.43%|#|大唐电信|3.97%|#|广合科技|3.84%|#|积成电子|3.77%|康希诺所在的生物制品行业，今日主力净流出2.41亿元，行业排名54/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217155038ab7e83bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217155038ab7e83bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2492677324","title":"《股市简讯》中国康希诺A/H股齐涨，婴幼儿百白破疫苗上市申请获药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2492677324","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492677324?lang=zh_cn&edition=full","pubTime":"2024-12-17 10:13","pubTimestamp":1734401629,"startTime":"0","endTime":"0","summary":"《股市简讯》中国康希诺A/H股齐涨，婴幼儿百白破疫苗上市申请获药监局受理* 中国疫苗生产商--康希诺H股6185.HK周二早盘涨幅扩大至4%，其A股688185.SS亦一度升2.7%。* 该公司此前公告称，婴幼儿用吸附无细胞百（组分）白破联合疫苗的新药上市申请已于近日获得中国国家药监局出具的受理通知书。目前暂无国产组分百白破疫苗获批在中国上市，公司的婴幼儿用DTcP在中国的定位即为进口疫苗的可行替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4T3NI04H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","BK1515","BK1574","688185","06185","BK0239"],"gpt_icon":0},{"id":"2491652863","title":"康希诺最新公告：婴幼儿用吸附无细胞百（组分）白破联合疫苗药品注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2491652863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491652863?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:00","pubTimestamp":1734339651,"startTime":"0","endTime":"0","summary":"康希诺公告，公司研发的婴幼儿用吸附无细胞百（组分）白破联合疫苗（婴幼儿用DTcP）境内生产药品注册上市许可申请于近日获得国家药品监督管理局出具的《受理通知书》。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600021793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2491542296","title":"康希诺：婴幼儿用组分白破联合疫苗注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2491542296","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491542296?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:59","pubTimestamp":1734339550,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688185","159646"],"gpt_icon":0},{"id":"2491665413","title":"康希诺(688185.SH)：婴幼儿用吸附无细胞百(组分)白破联合疫苗药品注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2491665413","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491665413?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:53","pubTimestamp":1734339218,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)发布公告，公司研发的婴幼儿用吸附无细胞百(组分)白破联合疫苗(简称“婴幼儿用DTcP”)境内生产药品注册上市许可申请于近日获得国家药品监督管理局出具的《受理通知书》，受理号：CXSS2400139。婴幼儿用DTcP向国家药品监督管理局递交药品注册申请获得受理后，还需经过技术审评、临床试验现场核查、生产现场检查等程序，待获得药品注册批件且产品获得批签发后方可上市销售。婴幼儿用DTcP审评审批进度及取得药品注册批件的时间具有一定的不确定性，待获批上市销售，将对公司经营业绩产生积极的影响，同时将丰富公司产品管线，进一步增强公司竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2491930138","title":"康希诺12月13日主力资金流出942万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491930138","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491930138?lang=zh_cn&edition=full","pubTime":"2024-12-13 15:21","pubTimestamp":1734074465,"startTime":"0","endTime":"0","summary":"12月13日, 康希诺股价跌3.23%，报收64.39元，成交金额1.12亿元，换手率1.50%，振幅3.13%，量比0.71。康希诺今日主力资金净流出942万元，连续5日净流出，上一交易日主力净流出1794万元，今日环比减少47.49%。该股近5个交易日下跌8.50%，主力资金累计净流出7201万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1.30亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154608ab74ad62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213154608ab74ad62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2491608363","title":"康希诺在互动平台表示，公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报。","url":"https://stock-news.laohu8.com/highlight/detail?id=2491608363","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491608363?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:11","pubTimestamp":1734052310,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["CDE","BK4017","BK0239","159646","688185"],"gpt_icon":0},{"id":"2490806136","title":"康希诺：公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报","url":"https://stock-news.laohu8.com/highlight/detail?id=2490806136","media":"证星董秘互动","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490806136?lang=zh_cn&edition=full","pubTime":"2024-12-12 19:00","pubTimestamp":1734001250,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺(688185)12月12日在投资者关系平台上答复投资者关心的问题。投资者：您好，截止12月10日，贵司A股股东人数有多少？康希诺董秘：尊敬的投资人您好，根据中国证券登记结算有限责任公司下发的公司2024年12月10日A股股东名册，持有人数为19158人。谢谢！投资者：您好，CDE官网显示，贵司11月15日申请的II类会议已反馈，请问，是什么沟通交流？康希诺董秘：尊敬的投资人您好，公司正在推进多款创新疫苗的研发工作，按照CDE的指导原则对相关事项提交申请，并积极沟通汇报。如有阶段性进展，会及时分享。谢谢！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212190220ab723aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212190220ab723aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","BK1515","BK1574","06185","688185"],"gpt_icon":0},{"id":"2490425478","title":"康希诺生物盘中异动 早盘急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490425478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490425478?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:31","pubTimestamp":1733970695,"startTime":"0","endTime":"0","summary":"2024年12月12日早盘10时31分，康希诺生物股票出现波动，股价急速跳水5.11%。截至发稿，该股报31.600港元/股，成交量63.16万股，换手率0.48%，振幅5.11%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体跌幅为0.30%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212103135ab71287a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212103135ab71287a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","688185","BK1515","BK1574","06185"],"gpt_icon":0},{"id":"2490841395","title":"南向资金12月11日净买入康希诺生物8.46万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490841395","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490841395?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:30","pubTimestamp":1733967026,"startTime":"0","endTime":"0","summary":"12月11日, 南向资金增持康希诺生物8.46万股，连续5日增持。截止当日收盘，港股通共持有康希诺生物4556.00万股，占流通股34.33%。康希诺生物近5个交易日上涨11.56%，港股通累计增持74.96万股；近20个交易日上涨5.21%，港股通累计增持289.12万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093303ab710180&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093303ab710180&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1161","BK1515","BK1574","06185","688185"],"gpt_icon":0},{"id":"2490384869","title":"康希诺（688185）12月11日主力资金净卖出1330.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490384869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490384869?lang=zh_cn&edition=full","pubTime":"2024-12-12 08:25","pubTimestamp":1733963134,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月11日收盘，康希诺报收于67.55元，下跌1.37%，换手率1.65%，成交量1.89万手，成交额1.29亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入1118.26万元，融资偿还1099.26万元，融资净买入19.0万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200006787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688185","BK0239"],"gpt_icon":0},{"id":"2490617968","title":"康希诺12月11日主力资金流出1164万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490617968","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490617968?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:20","pubTimestamp":1733901629,"startTime":"0","endTime":"0","summary":"12月11日, 康希诺股价跌1.37%，报收67.55元，成交金额1.29亿元，换手率1.65%，振幅3.50%，量比0.79。康希诺今日主力资金净流出1164万元，连续3日净流出，上一交易日主力净流出1055万元，今日环比增加10.33%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为48.00%，平均跌幅为2.29%。该股近5个交易日上涨2.88%，主力资金累计净流出1903万元；近20日主力资金累计净流出1.44亿元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211153831ab6ee3a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211153831ab6ee3a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2490036170","title":"康希诺生物盘中异动 急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490036170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490036170?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:48","pubTimestamp":1733881696,"startTime":"0","endTime":"0","summary":"2024年12月11日早盘09时48分，康希诺生物股票出现波动，股价大幅拉升5.14%。截至发稿，该股报34.750港元/股，成交量17.82万股，换手率0.13%，振幅5.14%。康希诺生物股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，思路迪医药股份、药明巨诺-B、康希诺生物涨幅较大，振幅较大的相关个股有晶泰控股-P、思路迪医药股份、北海康成-B，振幅分别为10.39%、9.01%、5.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094816a1e4c935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211094816a1e4c935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1161","BK1191","BK1515","BK1574","688185"],"gpt_icon":0},{"id":"2490038004","title":"康希诺（688185）12月9日主力资金净卖出2400.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490038004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490038004?lang=zh_cn&edition=full","pubTime":"2024-12-10 08:24","pubTimestamp":1733790267,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月9日收盘，康希诺报收于68.29元，下跌2.96%，换手率2.07%，成交量2.38万手，成交额1.64亿元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入1488.84万元，融资偿还1731.33万元，融资净偿还242.49万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000009060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2489728647","title":"康希诺12月06日获主力加仓2540万元 环比增加10943.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489728647","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489728647?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:19","pubTimestamp":1733469587,"startTime":"0","endTime":"0","summary":"12月06日, 康希诺股价涨4.97%，报收70.37元，成交金额2.40亿元，换手率3.02%，振幅5.21%，量比1.57。康希诺今日主力资金净流入2540万元，上一交易日主力净流入23万元，今日环比增加10943.48%。该股近5个交易日上涨5.82%，主力资金累计净流出1253万元；近20日主力资金累计净流出7544万元，其中净流出天数为12日。该行业中净流入前三个股分别为智飞生物、天坛生物、康希诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153211ab61ed5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153211ab61ed5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2489286401","title":"康希诺股价涨5% 券商看多","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286401","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286401?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:10","pubTimestamp":1733465457,"startTime":"0","endTime":"0","summary":"12月06日，康希诺股价大幅上涨，截至14点10分，康希诺上涨5.09%，报70.45元/股，突破70元整数关口，成交1.87亿元，换手率2.37%。资金动向截止发稿，康希诺获得主力净流入2245万元，其中超大单流入1544万元，大单流入700万元。融资融券方面，康希诺12月04日获得融资净买入244万元，当日该股融资余额为3.15亿元，当较前一日增加0.78%；该股融券余额为57万元，融券余量为0.81万股，比上日减少4.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206141103ab61c52b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206141103ab61c52b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2489424837","title":"康希诺生物盘中异动 早盘急速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489424837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489424837?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:21","pubTimestamp":1733455277,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘11时21分，康希诺生物股票出现波动，股价急速上涨5.17%。截至发稿，该股报33.550港元/股，成交量111.41万股，换手率0.84%，振幅5.33%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，北海康成-B、巨子生物、云康集团涨幅较大，振幅较大的相关个股有北海康成-B、来凯医药-B、永泰生物-B，振幅分别为29.23%、13.75%、13.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112117971c054c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112117971c054c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06185","BK1515","BK1574","688185","BK1191","BK1161"],"gpt_icon":0},{"id":"2489705651","title":"康希诺现涨超5% 近日MCV4药品补充申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2489705651","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489705651?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:54","pubTimestamp":1733367240,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 康希诺（06185）早盘上涨5.51%，现报31.50港元，成交额3689.00万港元。\n 康希诺发布公告，公司的ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体）（简称“MCV4”）药品补充申请于近日获得国家药品监督管理局出具的《受理通知书》，受理号：CYSB2400306。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-05/doc-incyknpv3177225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688185"],"gpt_icon":0},{"id":"2489172436","title":"港股异动 | 康希诺(06185)涨超4% 近日MCV4药品补充申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2489172436","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489172436?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:22","pubTimestamp":1733365352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康希诺涨超4%，截至发稿，涨4.52%，报31.2港元，成交额2093.8万港元。消息面上，康希诺发布公告，公司的ACYW135群脑膜炎球菌多糖结合疫苗药品补充申请于近日获得国家药品监督管理局出具的《受理通知书》，受理号：CYSB2400306。本次补充申请为MCV4的适用人群年龄范围由“3月龄~3周岁儿童”扩大至“3月龄~6周岁儿童”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06185","688185","BK1515","BK0239","BK1161","BK1191","BK1574"],"gpt_icon":0},{"id":"2489172883","title":"康希诺生物盘中异动 早盘股价大涨5.19%报31.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489172883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489172883?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:06","pubTimestamp":1733364407,"startTime":"0","endTime":"0","summary":"2024年12月05日早盘10时06分，康希诺生物股票出现波动，股价快速拉升5.19%。截至发稿，该股报31.400港元/股，成交量48.6916万股，换手率0.37%，振幅5.86%。资金方面，该股资金流入884.987万港元，流出417.145万港元。康希诺生物股票所在的生物技术行业中，整体跌幅为1.15%。其相关个股中，帝王国际投资、康希诺生物、百奥赛图-B涨幅较大，振幅较大的相关个股有晶泰科技、药明巨诺-B、腾盛博药-B，振幅分别为15.84%、9.92%、9.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205100648ab5e7667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205100648ab5e7667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","688185","BK1515","BK1574","06185"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","stockEarnings":[{"period":"1week","weight":-0.0631},{"period":"1month","weight":0.0218},{"period":"3month","weight":0.5437},{"period":"6month","weight":0.4335},{"period":"1year","weight":-0.1775},{"period":"ytd","weight":-0.1507}],"companyName":"康希诺生物股份公司","boardCode":"AI0027","perCapita":"5991股","boardName":"医药制造业","registeredCapital":"24744万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。","serverTime":1734598493079,"listedPrice":209.71,"stockholders":"19158人(较上一季度增加Infinity%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}